Asian Journal of Social Pharmacy ›› 2020, Vol. 15 ›› Issue (3): 171-177.

Previous Articles     Next Articles

Research on Relief Models of Mass Tort of Vaccine

Yang Lina, Huang Zhe*   

  1. School of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China
  • Online:2020-09-20 Published:2020-09-15
  • Contact: Huang Zhe, professor. Major research area: medical investment performance and management, etc. Tel: 024- 23986543, E-mail: huangzhe2000@sina.com. E-mail:huangzhe2000@sina.com

Abstract: Objective To solve the problem of the incomplete relief model for vaccine damage events in China, multiple models for large-scale vaccine damage events were established based on the cooperation of product liability, compulsory insurance and rescue funds. Methods Through case analysis and comparative research, the situation of liability sharing and relief of mass tort of vaccines was analyzed. Results and Conclusion At present, China should construct a multi-relief model of vaccine damage from the aspects of tort liability and social relief. In addition, after the construction of the relief system, it is necessary to distinguish between emergency situations and general situations to apply the priority of tort compensation and social relief systems in the specific implementation process.

Key words: vaccine damage, quality issues, mass tort, relief path

Trendmd